Trials / Completed
CompletedNCT01448226
Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy
Diagnosing Invasive Aspergillosis by PCR Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 221 (actual)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 5 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Invasive pulmonary aspergillosis (IPA) remains a major cause for morbidity and mortality in patients (pts) with hematologic malignancies. As culture-based methods only yield results in a minority of patients, using non-culture-based methods for detection of aspergillosis in clinical specimens becomes increasingly important. Analyzing bronchoalveolar lavage (BAL) samples with polymerase chain reaction (PCR) is promising, however, the influence of current antifungal drugs on the performance of this diagnostic tool remains controversial. The aim of the trial is to elucidate on the performance of BAL PCR under antifungal treatment.
Detailed description
Invasive pulmonary aspergillosis (IPA) remains a major cause for morbidity and mortality in patients (pts) with hematologic malignancies. As culture-based methods only yield results in a minority of patients, using non-culture-based methods for detection of aspergillosis in clinical specimens becomes increasingly important. Analyzing bronchoalveolar lavage (BAL) samples with polymerase chain reaction (PCR) is promising, however, the influence of current antifungal drugs on the performance of this diagnostic tool remains controversial. The aim of the trial is to elucidate on the performance of BAL PCR under antifungal treatment. Patients with high risk of invasive aspergillosis and lung infiltrates are sampled via BAL, the sample is analyzed for fungal DNA by Apsergillus specific PCR. Clinical data including treatment data is assessed and evaluated.
Conditions
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2011-01-01
- Completion
- 2011-05-01
- First posted
- 2011-10-07
- Last updated
- 2020-04-20
Locations
22 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01448226. Inclusion in this directory is not an endorsement.